| MR编号 | DE/V/0229/001 |
|---|
| 药品名称 | Gallimune 407 ND+IB+EDS+ART |
|---|
| 活性成分 | - EDSV strain V127 162.0 HI
- IBV strain Massachussetts 41 10.0 HI
- NDV strain Ulster 2c 10.0 HI
- Turkey Rhinotracheitis virus 60.0 IP.
|
|---|
| 剂型 | Emulsion for injection |
|---|
| 上市许可持有人 | Merial
29 avenue Tony Garnier
BP 7123
F- 69348 Lyon CEDEX 07 |
|---|
| 参考成员国 - 产品名称 | Germany (DE) |
|---|
| 互认成员国 - 产品名称 | - Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Hungary (HU)
- Cyprus (CY)
- Czechia (CZ)
- Slovakia (SK)
- Slovenia (SI)
- United Kingdom (Northern Ireland) (XI)
|
|---|
| 许可日期 | 2004/07/28 |
|---|
| 最近更新日期 | 2025/01/28 |
|---|
| 药物ATC编码 | - QI01AA Inactivated viral vaccines
|
|---|
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full Dossier (art.5)
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|